Literature DB >> 16896150

Hepatitis delta virus infection in mongolia: analyses of geographic distribution, risk factors, and disease severity.

Dambadarjaa Davaalkham1, Toshiyuki Ojima, Ritei Uehara, Makoto Watanabe, Izumi Oki, Pagvajav Nymadawa, Masaharu Takahashi, Hiroaki Okamoto, Yosikazu Nakamura.   

Abstract

The prevalence and risk factors for hepatitis delta virus (HDV) infection among Mongolian school children were assessed by detecting the antibody against HDV and HDV RNA, and through structured interviews. The study subjects consisted of 181 children with the past or ongoing hepatitis B virus infection who were investigated during the nationwide serosurvey conducted in 2004. The prevalence of antibody to HDV was 6.1%, with the proportion of 13.6% among hepatitis B surface antigen (HBsAg)-positive subjects, all of whom had HDV RNA. Multivariate logistic regression analyses showed that injections (> 11 times) (odds ratio [OR] = 8.31, 95% confidence interval [CI] = 1.28-54.07) and blood sampling (> 3 times) (OR = 5.34, 95% CI = 1.12-25.53) in health care settings, hospitalization (> 3 times) (OR = 6.20, 95% CI = 1.18-32.71), and cohabitating with patients with chronic hepatitis (OR = 4.57, 95% CI = 1.26-16.55) predicted the seropositivity for antibody to HDV. These results suggest that parenteral exposures in health care settings and household transmission are the main routes of HDV transmission among Mongolian children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896150

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.

Authors:  Xiaohua Chen; Odgerel Oidovsambuu; Ping Liu; Rosslyn Grosely; Menashe Elazar; Virginia D Winn; Benjamin Fram; Zhang Boa; Hongjie Dai; Bekhbold Dashtseren; Dahgwahdorj Yagaanbuyant; Zulkhuu Genden; Naranbaatar Dashdorj; Andreas Bungert; Naranjargal Dashdorj; Jeffrey S Glenn
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

2.  Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.

Authors:  Davaalkham Dambadarjaa; Yerkyebulan Mukhtar; Enkh-Oyun Tsogzolbaatar; Ser-Od Khuyag; Angarmurun Dayan; Nandin-Erdene Oyunbileg; Oyu-Erdene Shagdarsuren; Gunchmaa Nyam; Yosikazu Nakamura; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Prev Med Public Health       Date:  2022-05-20

Review 3.  Pathogenesis of and New Therapies for Hepatitis D.

Authors:  Christopher Koh; Theo Heller; Jeffrey S Glenn
Journal:  Gastroenterology       Date:  2018-10-18       Impact factor: 22.682

4.  High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam.

Authors:  Bui Tien Sy; Boris A Ratsch; Nguyen Linh Toan; Le Huu Song; Christian Wollboldt; Agnes Bryniok; Hung Minh Nguyen; Hoang Van Luong; Thirumalaisamy P Velavan; Heiner Wedemeyer; Peter G Kremsner; C-Thomas Bock
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

5.  Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.

Authors:  Yoona A Kim; Jacqueline Estevez; An Le; Dennis Israelski; Oidov Baatarkhuu; Tserenchimed Sarantuya; Sonom Narantsetseg; Pagbajabyn Nymadawa; Richard H Le; Man-Fung Yuen; Geoffrey Dusheiko; Mario Rizzetto; Mindie H Nguyen
Journal:  BMJ Open Gastroenterol       Date:  2016-11-10

6.  Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: A single-center study.

Authors:  Ghazi A Jamjoom; Mai M El-Daly; Esam I Azhar; Hind I Fallatah; Hisham O Akbar; Mohammed Babatin; Abdullah S Alghamdi; Mohammed I Dgdgi; Mohamed A Hamid; Yousef A Qari; Sherif A El-Kafrawy
Journal:  Saudi J Gastroenterol       Date:  2017 May-Jun       Impact factor: 2.485

Review 7.  Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia.

Authors:  Oidov Baatarkhuu; Tsagaantsooj Gerelchimeg; Dashchirev Munkh-Orshikh; Badamnachin Batsukh; Ganbold Sarangua; Jazag Amarsanaa
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.